Pacira Pharmaceuticals Inc (PCRX) Insider Trading
- $1,702,348.30
- $213,358,603.47
- April 23, 2026
- Andreas Wicki
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| April 23, 2026 | CFO | 12,941 | $25.16 | Sell | $325,595.56 | |
| April 22, 2026 | CFO | 1,500 | $25.01 | Sell | $37,515.00 | |
| April 21, 2026 | CFO | 2,845 | $25.01 | Sell | $71,153.45 | |
| April 20, 2026 | CFO | 7,714 | $25.14 | Sell | $193,929.96 | |
| March 17, 2026 | Insider | 3,261 | $22.82 | Sell | $74,416.02 | |
| Feb. 2, 2026 | SVP | 4,000 | $20.81 | Sell | $83,240.00 | |
| Aug. 7, 2025 | Director | 4,912 | $23.67 | Sell | $116,267.04 | |
| June 4, 2025 | SVP | 5,578 | $26.21 | Sell | $146,199.38 | |
| Jan. 6, 2025 | Insider | 879 | $18.40 | Sell | $16,173.60 | |
| Dec. 13, 2024 | COO | 500 | $19.76 | Sell | $9,880.00 | |
| Sept. 13, 2024 | COO | 500 | $12.86 | Sell | $6,430.00 | |
| Aug. 16, 2024 | Director | 1,512 | $13.25 | Buy | $20,034.00 | |
| Aug. 12, 2024 | Director | 1,400 | $11.58 | Buy | $16,212.00 | |
| Aug. 12, 2024 | CEO | 8,264 | $12.10 | Buy | $99,994.40 | |
| Aug. 2, 2024 | Insider | 945 | $20.05 | Sell | $18,947.25 | |
| July 2, 2024 | Insider | 2,836 | $28.25 | Sell | $80,117.00 | |
| June 13, 2024 | COO | 1,000 | $28.38 | Sell | $28,380.00 | |
| June 13, 2024 | Director | 880 | $28.38 | Sell | $24,974.40 | |
| June 13, 2024 | Insider | 7,452 | $28.38 | Sell | $211,487.76 | |
| June 12, 2024 | SVP | 3,970 | $28.72 | Sell | $114,018.40 | |
| June 11, 2024 | Insider | 5,012 | $28.57 | Sell | $143,192.84 | |
| March 8, 2024 | Director | 90,000 | $30.60 | Sell | $2,754,000.00 | |
| March 6, 2024 | Director | 1,066 | $29.67 | Sell | $31,628.22 | |
| Aug. 2, 2023 | Insider | 509 | $34.88 | Sell | $17,753.92 | |
| July 5, 2023 | SVP | 643 | $38.91 | Sell | $25,019.13 | |
| June 14, 2023 | SVP | 6,366 | $38.42 | Sell | $244,581.72 | |
| June 14, 2023 | Insider | 6,467 | $37.03 | Sell | $239,473.01 | |
| June 8, 2023 | Director | 15,000 | $37.04 | Sell | $555,600.00 | |
| June 7, 2023 | COO | 1,047 | $37.87 | Sell | $39,649.89 | |
| June 6, 2023 | Insider | 1,779 | $38.99 | Sell | $69,363.21 | |
| June 6, 2023 | SVP | 591 | $38.99 | Sell | $23,043.09 | |
| June 6, 2023 | CEO | 5,058 | $38.99 | Sell | $197,211.42 | |
| June 6, 2023 | CFO | 1,236 | $38.99 | Sell | $48,191.64 | |
| June 5, 2023 | Director | 580 | $38.34 | Sell | $22,237.20 | |
| June 5, 2023 | COO | 1,000 | $38.74 | Sell | $38,740.00 | |
| May 31, 2023 | COO | 2,500 | $39.08 | Sell | $97,700.00 | |
| May 11, 2023 | Director | 5,015 | $41.78 | Sell | $209,526.70 | |
| Jan. 5, 2023 | Insider | 546 | $38.31 | Sell | $20,917.26 | |
| Oct. 7, 2022 | Insider | 1,380 | $58.00 | Sell | $80,040.00 | |
| Aug. 3, 2022 | Insider | 476 | $55.70 | Sell | $26,513.20 | |
| July 11, 2022 | N/A | 533 | $56.95 | Sell | $30,354.35 | |
| July 5, 2022 | Insider | 924 | $57.19 | Sell | $52,843.56 | |
| June 8, 2022 | Insider | 4,937 | $59.82 | Sell | $295,331.34 | |
| June 8, 2022 | CEO | 13,828 | $59.85 | Sell | $827,605.80 | |
| June 6, 2022 | Insider | 17,546 | $61.39 | Sell | $1,077,148.94 | |
| June 6, 2022 | SVP | 1,150 | $61.37 | Sell | $70,575.50 | |
| June 6, 2022 | CEO | 11,965 | $61.37 | Sell | $734,292.05 | |
| June 6, 2022 | COO | 1,106 | $61.37 | Sell | $67,875.22 | |
| June 6, 2022 | CFO | 2,516 | $61.37 | Sell | $154,406.92 | |
| May 9, 2022 | Director | 1,000 | $59.37 | Sell | $59,370.00 |
Insiders are both buying and selling Pacira Pharmaceuticals Inc stock.
The insider traders at Pacira Pharmaceuticals Inc are: Andreas Wicki, Lauren Bullaro Riker, David M Stack, Kristen Marie Williams, David M. Stack, Paul J Hastings, James S Scibetta, Roy Winston, Max Reinhardt, Daryl Gaugler, Gary W Pace, Charles A Reinhart III, Jonathan Slonin, John P Phd Longenecker, Gary Patou, Charles Anthony Laranjeira, Mark A Kronenfeld, Shawn Cross, Taunia Markvicka, Lauren Riker, Luke Evnin, Mark Froimson, Richard Scranton, David Stack, Fred A Middleton, James B Jones, Anthony Molloy, James Scibetta, Scott Braunstein, John Phd Longenecker, John Pratt, Marcelo Bigal, Laura Brege, James B. Jones, HASTINGS PAUL J, Kristen Williams, Dennis L Winger, Frank D Lee, Donald C Manning, Dennis Mcloughlin, and James S. Scibetta
The most active insider trader at Pacira Pharmaceuticals Inc is Andreas Wicki with 38 trades.
Andreas Wicki has sold the most Pacira Pharmaceuticals Inc stock with a total value of $103,301,745.13.
Gary W Pace has bought the most Pacira Pharmaceuticals Inc stock with a total value of $714,610.00.
The most recent insider trade for Pacira Pharmaceuticals Inc was on April 23, 2026.
The single biggest insider buy for Pacira Pharmaceuticals Inc was from James S Scibetta with a total value of $306,850.00 on Sept. 11, 2015.
The single biggest insider sell for Pacira Pharmaceuticals Inc was from Andreas Wicki with a total value of $15,187,500.00 on Aug. 11, 2014.
